News
Increased TGF-β1 promotes the phosphorylation and nuclear translocation of Smad2/3, sequentially activating the transcription ...
Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy
Few studies have directly compared the renoprotective effects of angiotensin II–receptor blockers and angiotensin-converting–enzyme (ACE) inhibitors in persons with type 2 diabetes.
In patients with type 2 diabetes who were receiving metformin, the novel once-weekly dual glucose-dependent insulinotropic polypeptide–GLP-1 receptor agonist tirzepatide was noninferior and ...
The Swedish biotech has unveiled final phase 2a data showing the angiotensin II type 2 receptor agonist improves lung function. Specifically, patients who received the drug saw an average 216-mL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results